Table 2.
Causative agents of bloodstream infection in patients with solid tumors.
| Causative Agent | Marin et al. 2014 [26] N = 528 (%) | Anatoliotaki et al. 2004 [27] N = 157 (%) |
|---|---|---|
| Gram-negative bacteria | 291 (55) | 73 (47) |
| Escherichia coli | 161 (55) | 39 (25) |
| Pseudomonas aeruginosa | 52 (18) | 11 (7) |
| Klebsiella spp. | 56 (10.6) | 3 (2) |
| Enterobacter spp | 27 (5.1) | 5 (1) |
| Proteus spp. | 10 (3) | 2 (1) |
| Salmonella spp | 8 (3) | 7 (4.5) |
| Aeromonas hydrophila | 4 (1) | — |
| Acinetobacter baumannii | 2 (1) | 1 (1) |
| Other Gram-negative bacteria | — | 5 (1) |
| Gram-positive bacteria | 184 (35) | 54 (34) |
| Viridans group streptococci | 40 (22) | 6 (4) |
| Staphylococcus aureus including MRSA | 38 (21) | 11 (7) |
| Enterococcus spp. | 33 (18) | 4 (2.5) |
| Coagulase-negative staphylococci | 30 (16) | 24 (15) |
| Streptococcus pneumoniae | 28 (15) | 3 (2) |
| Listeria monocytogenes | 16 (9) | — |
| Streptococcus bovis | 9 (5) | — |
| Corynebacterium spp | 2 (1) | 5 (3) |
| Other Gram-positive bacteria | — | 1 (0.5) |
| Anaerobes | 25 (4.5) | 5 (3) |
| Polymicrobial | 24 (4.5) | 22 (14) |
| MDR Gram-negative bacilli | 43 (15) | — |
| MDR Gram-positive and Gram-negative bacteria | 61 (13) | — |
MDR: multidrug resistant
MRSA: methicillin.resistant Staphylococcus aureus.